Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis

<div>Therapy timeline with serum creatinine level from presentation to December 2014. Shaded area represents TPE therapy. IVMP, intravenous methylprednisolone; HD, haemodialysis; IVIg, intravenous immunoglobulin; PLEX, TPE.</div>

Case Reports in Nephrology

fig2

Figure 2

Figure 2: Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis 